Accès ouvert
2023
article
OpenAlex
Susan M. Gapstur, Véronique Bouvard, Suzanne Tanya Nethan, Jo L. Freudenheim et autres
The IARC convened a group of scientists to review the evidence on reduction or cessation of alcohol beverage consumption in relation to alcohol-related cancer incidence or mortality.
us, fr, au, ca, gb, de, fi, br
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Eric S. Orman, Archita P. Desai, Marwan Ghabril, Lauren Nephew et autres
INTRODUCTION: Hospital readmissions are common in patients with cirrhosis, but there are few studies describing readmission preventability. We aimed to describe the incidence, causes, and risk factors for preventable readmission in this population. METHODS: We performed a prospective cohort study of patients …
us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
J Smith, Amy B. Kressel, Randall W. Grout, Bree Weaver et autres
Objective: To determine if race-ethnicity is correlated with case-fatality rates among low-income patients hospitalized for COVID-19. Research Design: Observational cohort study using electronic health record data. Patients: All patients assessed for COVID-19 from March 2020 to January 2021 at one safety net …
us
(code pays fourni par la source)
2021
article
OpenAlex
Indira Bhavsar‐Burke, Claire Jansson‐Knodell, Ashley C. Gilmore, David W. Crabb
BACKGROUND: Malnutrition is a commonly encountered issue in patients with alcohol-associated liver disease. The role of nutritional supplementation in the management of alcohol-associated liver disease is integral to patient outcomes-it has been shown to decrease rates of hepatic encephalopathy, improve outcomes post-liver …
us
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Arun J. Sanyal, Patrick S. Kamath, Vijay H. Shah, Nanye Long et autres
To elucidate the genetic variability between heavy drinkers with and without alcoholic hepatitis.
us
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Romil Saxena, Megan Comerford, David W. Crabb, Ryan Cook et autres
Only a minority of heavy drinking individuals develop alcoholic hepatitis (AH), for unclear reasons. We analyzed data from the Translational Research and Evolving Alcoholic Hepatitis Treatment cohort: subjects who drink heavily with normal results from liver tests (controls) and patients with AH. …
us
(code pays fourni par la source)
2020
book-chapter
OpenAlex
Michael R. Lucey, Gene Y. Im, Jessica L. Mellinger, Gyöngyi Szabó et autres
us
(code pays fourni par la source)
2019
book-chapter
OpenAlex
Joan M. Carlson, Jon Agley, Ruth A. Gassman, Angela M. McNelis et autres
2019
article
OpenAlex
Julia Anderson, Claire Jansson‐Knodell, David W. Crabb
us
(code pays fourni par la source)
Accès ouvert
2019
article
OpenAlex
David W. Crabb, Gene Y. Im, Gyöngyi Szabó, Jessica L. Mellinger et autres
Supported by the American Association for the Study of Liver Diseases. Potential conflict of interest: Dr. Lucey received grants from Gilead, AbbVie and Pharmasolutions. Dr. Szabo consults and received grants from Allergan. She consults for Terra Firma, Glympse, Quest, Arrow, GLG, Salix …
us
(code pays fourni par la source)
Accès ouvert
2019
article
OpenAlex
Michael R. Lucey, Gene Y. Im, Jessica L. Mellinger, Gyöngyi Szabó et autres
Peer Reviewed
us
(code pays fourni par la source)
Accès ouvert
2019
article
OpenAlex
Wei Li, Edward L. Lin, Suthat Liangpunsakul, Jie Lan et autres
OBJECTIVES: Alcoholic hepatitis (AH) develops in approximately 30% of chronic heavy drinkers. The immune system of patients with AH is hyperactivated, yet ineffective against infectious diseases. Mucosal-associated invariant T (MAIT) cells are innate-like lymphocytes that are highly enriched in liver, mucosa, and …
us
(code pays fourni par la source)